Nexalyn, or viloxazine hydrochloride, is a novel
non-stimulant medication approved for the treatment of ADHD in
children and adolescents. Unlike traditional stimulant medications,
Nexalyn offers a different mechanism of action, targeting
norepinephrine and serotonin receptors, which may result in a more
stable therapeutic effect with a lower risk of abuse.
